CA2551963C - Compositions pharmaceutiques et traitement de l'arteriosclerose avec du cs-866 - Google Patents

Compositions pharmaceutiques et traitement de l'arteriosclerose avec du cs-866 Download PDF

Info

Publication number
CA2551963C
CA2551963C CA002551963A CA2551963A CA2551963C CA 2551963 C CA2551963 C CA 2551963C CA 002551963 A CA002551963 A CA 002551963A CA 2551963 A CA2551963 A CA 2551963A CA 2551963 C CA2551963 C CA 2551963C
Authority
CA
Canada
Prior art keywords
angiotensin
receptor antagonists
converting enzyme
enzyme inhibitors
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002551963A
Other languages
English (en)
Other versions
CA2551963A1 (fr
Inventor
Yoshio Tsujita
Toshihiko Fujiwara
Toshio Sada
Naoyuki Maeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Priority claimed from CA002261040A external-priority patent/CA2261040C/fr
Publication of CA2551963A1 publication Critical patent/CA2551963A1/fr
Application granted granted Critical
Publication of CA2551963C publication Critical patent/CA2551963C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002551963A 1996-07-15 1997-07-11 Compositions pharmaceutiques et traitement de l'arteriosclerose avec du cs-866 Expired - Lifetime CA2551963C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18436896 1996-07-15
JP8/184368 1996-07-15
CA002261040A CA2261040C (fr) 1996-07-15 1997-07-11 Compositions medicinales

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002261040A Division CA2261040C (fr) 1996-07-15 1997-07-11 Compositions medicinales

Publications (2)

Publication Number Publication Date
CA2551963A1 CA2551963A1 (fr) 1998-01-22
CA2551963C true CA2551963C (fr) 2009-06-23

Family

ID=36998219

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002551963A Expired - Lifetime CA2551963C (fr) 1996-07-15 1997-07-11 Compositions pharmaceutiques et traitement de l'arteriosclerose avec du cs-866

Country Status (1)

Country Link
CA (1) CA2551963C (fr)

Also Published As

Publication number Publication date
CA2551963A1 (fr) 1998-01-22

Similar Documents

Publication Publication Date Title
CA2261040C (fr) Compositions medicinales
JP4843172B2 (ja) 医薬処方物および卒中、糖尿病および/またはうっ血性心不全の予防におけるその使用
CA2241466C (fr) Composition pharmaceutique comprenant un antagoniste de l'angiotensine ii
JP4588877B2 (ja) Adp−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防
RU99103215A (ru) Фармацевтическая композиция
EP0425909A2 (fr) Méthode pour restaurer l'activité vasorelaxante des artères coronaires, amoindrie par l'athérosclérose ou l'hypercholestérolémie, en utilisant un inhibiteur de l'ACE
JP2008094852A (ja) 医薬
HK1020260B (en) Pharmaceutical compositions comprising cs-866 and insulin resistance improving agents and their use for the treatment of arteriosclerosis and xanthoma
JPH1081632A (ja) 医 薬
HK1021508A (en) Pharmaceutical composition
JPH1081633A (ja) 医薬組成物
HK1040189A1 (en) Use of cs-866 (olmesartan) in the manufacture of a medicament for treating arteriosclerosis
ITTO960379A1 (it) Composizione farmaceutica per malattie cardiovascolari e renali.
KR20040054665A (ko) 지방이영양증의 치료
SK5322000A3 (en) Use of thiazolidinediones for the treatment of hyperglycaemia

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170711